BioAtla Inc (BCAB)
3.13
+0.04
(+1.29%)
USD |
NASDAQ |
May 08, 16:00
3.19
+0.06
(+1.92%)
After-Hours: 20:00
BioAtla Total Liabilities (Quarterly): 48.99M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 48.99M |
| September 30, 2023 | 56.66M |
| June 30, 2023 | 55.12M |
| March 31, 2023 | 48.12M |
| December 31, 2022 | 45.40M |
| September 30, 2022 | 46.48M |
| June 30, 2022 | 48.54M |
| March 31, 2022 | 40.60M |
| Date | Value |
|---|---|
| December 31, 2021 | 43.60M |
| September 30, 2021 | 46.93M |
| June 30, 2021 | 38.68M |
| March 31, 2021 | 33.17M |
| December 31, 2020 | 34.96M |
| September 30, 2020 | 137.29M |
| December 31, 2019 | 65.35M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
33.17M
Minimum
Mar 2021
137.29M
Maximum
Sep 2020
52.66M
Average
46.93M
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Marinus Pharmaceuticals Inc | 154.14M |
| Equillium Inc | 27.96M |
| Poseida Therapeutics Inc | 170.18M |
| Biomea Fusion Inc | 33.18M |
| Candel Therapeutics Inc | 28.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 119.66M |
| Shareholders Equity (Quarterly) | 70.67M |